Cerecin Announces Publication of Clinical Study Demonstrating Promising Results of CER-0001 (tricaprilin) for Rare Pediatric Epilepsy

Study showed that the investigational ketogenic drug was generally well tolerated and demonstrated seizure reduction in infants with rare drug-resistant epileptic spasms. Phase 1/2a study supports further development as a metabolic therapy for rare developmental and epileptic...